Alzheimer’s Clinical Trials Consortium – Down Syndrome
To provide an optimal infrastructure, utilizing centralized resources and shared expertise, to accelerate the development of effective interventions for Alzheimer’s disease in Down syndrome.
![](https://live-usc-actc-ds.pantheonsite.io/wp-content/uploads/2020/06/image-grid-03@2x.png)
![](https://live-usc-actc-ds.pantheonsite.io/wp-content/uploads/2020/06/image-grid-02@2x.png)
![](https://live-usc-actc-ds.pantheonsite.io/wp-content/uploads/2020/06/image-grid-01@2x.png)
![](https://live-usc-actc-ds.pantheonsite.io/wp-content/uploads/2020/06/image-grid-04@2x.png)
Trial Ready-Cohort for Down Syndrome (TRC-DS).
The ACTC-DS recently launched the Trial Ready-Cohort for Down syndrome (TRC-DS). TRC-DS will enroll 250 participants with DS into a longitudinal study which includes brain scans, blood tests, memory tests in advance of upcoming randomized, placebo-controlled clinical trials for Alzheimer’s disease in Down syndrome. Participants in TRC-DS will be provided the opportunity to enroll into these clinical trials aimed at preventing Alzheimer’s disease in Down syndrome.
![](https://live-usc-actc-ds.pantheonsite.io/wp-content/uploads/2019/10/submit-hero-image-test.jpg)
![](https://live-usc-actc-ds.pantheonsite.io/wp-content/uploads/2020/06/Org-Chart.png)